https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-04-01 / Pneumologie 2004 Apr;58(4):210-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-04-01 / Pneumologie 2004 Apr;58(4):210-62004-04-01 00:00:002004-04-01 00:00:00[Evaluation of the therapeutic benefit of 41.8 degrees C whole body hyperthermia plus ifosfamide, carboplatin and etoposide (ICE) for patients with malignant pleural mesothelioma using the Modified Brunner-Score (MBS)]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-03-01 / Lung Cancer 2003 Mar;39(3):339-45
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-03-01 / Lung Cancer 2003 Mar;39(3):339-452003-03-01 00:00:002003-03-01 00:00:00Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-05-01 / Lung Cancer 2001 May;32(2):197-201
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-05-01 / Lung Cancer 2001 May;32(2):197-2012001-05-01 00:00:002001-05-01 00:00:00Localised spontaneous regression in mesothelioma — possible immunological mechanism
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-03-17 / Dtsch. Med. Wochenschr. 2000 Mar;125(11):317-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-03-17 / Dtsch. Med. Wochenschr. 2000 Mar;125(11):317-92000-03-17 00:00:002000-03-17 00:00:00[Chemotherapy in combination with whole-body hyperthermia in advanced malignant pleural mesothelioma]
